InvestorsHub Logo
Followers 0
Posts 8
Boards Moderated 0
Alias Born 09/10/2009

Re: None

Wednesday, 09/16/2009 1:34:15 PM

Wednesday, September 16, 2009 1:34:15 PM

Post# of 1529
2nd Qtr 2010 Sales

Hopefully some upward momentum will ensue...

http://pr-canada.net/index.php?option=com_content&task=view&id=124456&Itemid=65

Ventana Biotech Inc. ("Ventana") (PINK SHEETS:VNTA), a biotechnology company developing medicated chewing gums, today announced that it has signed a deal with GTMC, a Korean distribution company, for the distribution of Ventana's appetite suppressant and stress reducing chewing gums.

The deal will see Ventana's products distributed initially to South Korea and, later, to Japan through GTMC's network of manufacturing and distribution partners. Under the terms of the deal, GTMC will negotiate agreements whereby GTMC will cover the initial costs and, thereafter, manufacturing and distribution costs will be paid through revenue share agreements.

This arrangement enables Ventana to participate in the lucrative alternative biotech market without having to provide any of the upfront costs. In South Korea alone, the import of medical products has risen approximately 30% per year for the past 5 years. South Korea is among the top 15 economies in the world and its population expects a high level of medical care and choice of products. Medicated chewing gum is on the rise in South Korea and this agreement positions Ventana to be a leading supplier in an estimated billion dollar market in 2010.

Ventana's first shipments are expected to be distributed in South Korea no later than the second quarter of 2010.